Research Topic

Utilizing biospecimen repositories and health registries in life-course epidemiology - for early detection and prevention

About this Research Topic

The incidence of non-communicable diseases like cancer, cardiovascular disease, diabetes and chronic respiratory illnesses is increasing worldwide and constitute a large public health challenge. Many of those diseases share common risk factors and are to a large extent preventable, as they are associated with highly modifiable risk factors like smoking, physical inactivity, obesity and UV radiation. These modifiable risk factors may interact with each other, as well as with molecular factors and constitute a complex network of parameters that influence on biological processes in disease development and progression. There is a need to increase the knowledge on how these parameters works together in a beneficial or harmful direction on disease risk. To better understand this complexity of disease development it is a strength to utilize combined datasets from large cohorts comprising of high quality data from disease registries and surveys, with associated biological specimens and biomarker information. Preferably with data and/or samples from repeated time points before a diagnosis to be able to identify changes in risk factors and early detection biomarkers.
Biobanks have been in operation for many decades in large population-based initiatives as well as smaller hospital- based collections and have become a critical resource for medical research. The rapid development of technologies like genomic sequencing and high-throughput molecular analyses, as well as advances in biocomputational analyses tools, opens up for new opportunities in utilization of biobanked samples. So far most studies using biobanks are based on collections from patients, representing a molecular profile highly affected by disease. Prospectively collected biorepositories that are crucial for studies on aetiology and early detection are to a much less extent utilized. Linkage of biobanks to health data from registries and exposome data is allowing prospective analyses to be undertaken for research into the causes of a wide range of health outcomes.


Keywords: biorepositories, registries, prospective cohorts, biomarkers, prevention


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

The incidence of non-communicable diseases like cancer, cardiovascular disease, diabetes and chronic respiratory illnesses is increasing worldwide and constitute a large public health challenge. Many of those diseases share common risk factors and are to a large extent preventable, as they are associated with highly modifiable risk factors like smoking, physical inactivity, obesity and UV radiation. These modifiable risk factors may interact with each other, as well as with molecular factors and constitute a complex network of parameters that influence on biological processes in disease development and progression. There is a need to increase the knowledge on how these parameters works together in a beneficial or harmful direction on disease risk. To better understand this complexity of disease development it is a strength to utilize combined datasets from large cohorts comprising of high quality data from disease registries and surveys, with associated biological specimens and biomarker information. Preferably with data and/or samples from repeated time points before a diagnosis to be able to identify changes in risk factors and early detection biomarkers.
Biobanks have been in operation for many decades in large population-based initiatives as well as smaller hospital- based collections and have become a critical resource for medical research. The rapid development of technologies like genomic sequencing and high-throughput molecular analyses, as well as advances in biocomputational analyses tools, opens up for new opportunities in utilization of biobanked samples. So far most studies using biobanks are based on collections from patients, representing a molecular profile highly affected by disease. Prospectively collected biorepositories that are crucial for studies on aetiology and early detection are to a much less extent utilized. Linkage of biobanks to health data from registries and exposome data is allowing prospective analyses to be undertaken for research into the causes of a wide range of health outcomes.


Keywords: biorepositories, registries, prospective cohorts, biomarkers, prevention


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

30 June 2020 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

30 June 2020 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..